Navigation Links
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea

18, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders.

Research has shown that compounds can be created by chemically modifying certain tetracyclines and that these new compounds have properties that may make them effective in treating diseases involving inflammation and/or destruction of the body's connective tissues. CollaGenex is evaluating various chemically modified tetracyclines (so called "IMPACS" compounds because they are Inhibitors of Multiple Proteases And CytokineS") to assess whether they are safe and effective in these applications. The Company has a pipeline of innovative product candidates with possible applications in dermatology and other disease states. In addition, CollaGenex has acquired the SansRosa(TM) technology, which consists of a class of compounds that have shown promise in reducing the redness associated with rosacea, and the Restoraderm(R) technology, a unique, proprietary dermal drug delivery system. CollaGenex plans to leverage these platforms to develop a range of topical dermatological products with enhanced pharmacologic and cosmetic properties.

To receive additional information on the Company, please visit our Web site at www.collagenex.com, which does not form part of this press release.

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the Company's plans, timing and success related to its patent applications and the launch of Oracea for the treatment of inflammatory lesions of rosacea, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. CollaGenex' actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including those factors contained in the most recent Form 10-K for the yea
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
6. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
7. King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide
8. Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for Psychotic Major Depression Misses Primary Endpoint
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:6/30/2015)... , June 30, 2015 Pulse ... issued a survey to Rosacea sufferers as part of their ... treatments Rosacea sufferers found effective for their Rosacea. The survey ... and comprised 47% men and 53% women. The ... survey participants did not consider or attempt to visit their ...
(Date:6/30/2015)... First Choice Wellness Care recently upgraded their ... is the only clinic in the greater ... The practice has recently expanded their services and added ... their focus in the procedure. They upgraded to the ... clearance, and superior service. "We,ve been providing ...
(Date:6/30/2015)... ALISO VIEJO, Calif. , June 30, 2015 ... from the PRISM II study showing that treatment ... statistically significant reduction in symptoms of pseudobulbar affect ... or stroke. PBA is a distressing condition characterized ... crying resulting from certain neurologic diseases or brain ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
(Date:6/30/2015)... ... 2015 , ... According to a recent report by the U.S. Drug Enforcement ... than tripled in the same period—leading a majority of law enforcement agencies to cite ... leading Florida-based drug treatment facility, asserts that these heroin statistics point to an urgent ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... ... From the moment a patient enters the office of Dr. Breiterman at ... and the luxury in which they are bathed. The office has always offered ... same experience, just better! , Their office is a state-of the-art facility using only ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... ... executive vice president and general manager of HRA Healthcare Research & Analytics ... N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. HRA offers quantitative ...
(Date:6/30/2015)... ... ... Independence Day weekend is more than just fireworks to celebrate America’s birthday, ... as National Hot Dog Month. Americans are expected to eat more than 150 million ... and enough to stretch from Washington D.C. to Los Angeles more than five times. ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2
... Smoking cigarettes is not only the principle cause of ... the body,s immune responses to bacteria that commonly cause ... a mouse model. , "It is well established ... But our research also suggests that cigarette smoke substantially ...
... A group of Hollywood,s new moms, March of ... new public service announcement (PSA) to show their support ... that helps moms have full-term pregnancies and babies have ... )Volunteer moms include - Standing: Jenny Garth ...
... Mayer Laboratories, Inc., a marketer and distributor ... announced today that it has signed an agreement ... of the Today Sponge for the United States, ... Labs has marketed and distributed contraceptive and reproductive ...
... N.Y., April 6 Hands-on therapies are among the top-rated ... new survey by the Consumer ... Fifty-eight percent rated chiropractic/spinal manipulation as helping a lot. ... up. Consumers also rated their satisfaction with practitioners, telling ...
... of a drug from the adverse side effects , ... raising levels of "good" cholesterol and lowering levels of "bad" ... heart attack. However, patients often stop taking the drug due ... often includes an intense burning and itching sensation. A way ...
... Brief stress management sessions prior to and immediately after ... men undergoing a radical prostatectomy for early-stage prostate cancer, ... D. Anderson Cancer Center. , The study, in the ... , is the first to examine the benefits of ...
Cached Medicine News:Health News:Cigarette smoke may alter immune response in COPD exacerbations 2Health News:Cigarette smoke may alter immune response in COPD exacerbations 3Health News:Hollywood Moms Team Up For March For Babies 2Health News:Mayer Labs Acquires Today(R) Sponge Distribution Rights 2Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 2Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 3Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 4Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 5Health News:JCI online early table of contents: April 6, 2009 2Health News:JCI online early table of contents: April 6, 2009 3Health News:JCI online early table of contents: April 6, 2009 4Health News:JCI online early table of contents: April 6, 2009 5Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 2Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 3
... Designed to inform decision making, ... patient data on demand. Clinicians ... to lab results, medication profiles, ... profiles, and clinical notes such ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l, single-channel with adjustable-volume setting...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: